Form 4 for BSX Boston Scientific
Accepted 2022-11-30 00:00:00 ET · period of report 2022-11-29 · accession 0001225208-22-011987 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-11-30 | 2022-11-29 | BSX | Connors Nelda J | Dir | S - Sale | $44.47 | -18.2K | 27.2K | -40% | -$809.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-29 | S | D | 18,196 | $44.47 | 27,246 | I By Trust | — | — | (F1) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.47 to $44.485, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |